Structure and mechanism of sulfofructose transaldolase, a key enzyme in sulfoquinovose metabolism.

Schiff-base aldolase cryo-EM enzyme mechanism metabolism sulfonate sulfoquinovose sulfur cycle transaldolase

Journal

Structure (London, England : 1993)
ISSN: 1878-4186
Titre abrégé: Structure
Pays: United States
ID NLM: 101087697

Informations de publication

Date de publication:
02 03 2023
Historique:
received: 25 10 2022
revised: 15 12 2022
accepted: 25 01 2023
pubmed: 23 2 2023
medline: 8 3 2023
entrez: 22 2 2023
Statut: ppublish

Résumé

Sulfoquinovose (SQ) is a key component of plant sulfolipids (sulfoquinovosyl diacylglycerols) and a major environmental reservoir of biological sulfur. Breakdown of SQ is achieved by bacteria through the pathways of sulfoglycolysis. The sulfoglycolytic sulfofructose transaldolase (sulfo-SFT) pathway is used by gut-resident firmicutes and soil saprophytes. After isomerization of SQ to sulfofructose (SF), the namesake enzyme catalyzes the transaldol reaction of SF transferring dihydroxyacetone to 3C/4C acceptors to give sulfolactaldehyde and fructose-6-phosphate or sedoheptulose-7-phosphate. We report the 3D cryo-EM structure of SF transaldolase from Bacillus megaterium in apo and ligand bound forms, revealing a decameric structure formed from two pentameric rings of the protomer. We demonstrate a covalent "Schiff base" intermediate formed by reaction of SF with Lys89 within a conserved Asp-Lys-Glu catalytic triad and defined by an Arg-Trp-Arg sulfonate recognition triad. The structural characterization of the signature enzyme of the sulfo-SFT pathway provides key insights into molecular recognition of the sulfonate group of sulfosugars.

Identifiants

pubmed: 36805128
pii: S0969-2126(23)00031-X
doi: 10.1016/j.str.2023.01.010
pii:
doi:

Substances chimiques

Transaldolase EC 2.2.1.2
sulfoquinovose 3458-06-8
Fructose-Bisphosphate Aldolase EC 4.1.2.13
Methylglucosides 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

244-252.e4

Subventions

Organisme : Medical Research Council
ID : MR/T040742/1
Pays : United Kingdom
Organisme : Biotechnology and Biological Sciences Research Council
ID : BB/W003805/1
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 206161/Z/17/Z
Pays : United Kingdom

Informations de copyright

Copyright © 2023 The Author(s). Published by Elsevier Ltd.. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of interests The authors declare no competing interests.

Auteurs

Alexander J D Snow (AJD)

Department of Chemistry, York Structural Biology Laboratory, York YO10 5DD, UK.

Mahima Sharma (M)

Department of Chemistry, York Structural Biology Laboratory, York YO10 5DD, UK.

Palika Abayakoon (P)

School of Chemistry, University of Melbourne, Parkville, VIC 3010, Australia; Bio21 Molecular Science and Biotechnology Institute, University of Melbourne, Parkville, VIC 3010, Australia.

Spencer J Williams (SJ)

School of Chemistry, University of Melbourne, Parkville, VIC 3010, Australia; Bio21 Molecular Science and Biotechnology Institute, University of Melbourne, Parkville, VIC 3010, Australia. Electronic address: sjwill@unimelb.edu.au.

James N Blaza (JN)

Department of Chemistry, York Structural Biology Laboratory, York YO10 5DD, UK. Electronic address: jamie.blaza@york.ac.uk.

Gideon J Davies (GJ)

Department of Chemistry, York Structural Biology Laboratory, York YO10 5DD, UK. Electronic address: gideon.davies@york.ac.uk.

Articles similaires

Fructose-Bisphosphate Aldolase Animals Brucellosis Mice Humans
Humans Neoplasms Drug Resistance, Neoplasm Antineoplastic Agents Fructose-Bisphosphate Aldolase
Animals Fructose Intolerance Mice AMP Deaminase Fructose-Bisphosphate Aldolase
Streptomyces Transaldolase Threonine Biocatalysis Amino Acids

Classifications MeSH